Calendar

<<  May 2017  >>
MoTuWeThFrSaSu
24252627282930
1234567
891011121314
15161718192021
22232425262728
2930311234

View posts in large calendar

California scientists test Ecstasy as anxiety-reducer for gravely ill

From Reuters:

California scientists are testing whether the illegal psychoactive drug commonly known as Ecstasy could help alleviate anxiety for terminally ill patients, the trial's principal funder said on Tuesday.

At least a dozen subjects with life-threatening diseases like cancer, and who are expected to live at least 9 months, will participate in the double-blind trial over the next year in Santa Cruz, said Brad Burge, spokesman for the Multidisciplinary Association for Psychedelic Studies, in Santa Cruz.

Each subject will be randomly given either a full dose - 125 milligrams of MDMA, or an "active placebo" dose of 30 milligrams, Burge said.

Burge said the goal is to test whether gravely ill patients suffering from debilitating anxiety, fear or depression due to their diagnoses can find a measure of peace during the extended ecstasy-influenced psychotherapy sessions.

"Our hypothesis is that something is happening with MDMA that makes psychotherapy easier," Burge said.

Posted: 5/27/2015 9:34:00 AM

Tags: , , ,

New Webinar- “Flakka”: The Truth Behind the Latest Designer Drug Media Storm

From: NMS Labs

Donna Papsun, a forensic toxicologist at NMS Labs, will be hosting a free webinar on Flakka, the new dangerous designer drug that is taking the country by storm.  "Flakka” is the latest street name referring to alpha-pyrrolidinophenone (alpha PVP), a novel psychoactive substance that has been on the recreational drug market since 2012.  Former street names include “Gravel”, which was allegedly alpha PVP mixed with lorazepam, and “Bath Salts”, a catch-all term referring to a number of synthetic stimulants.  This webinar will focus on the toxicology of alpha PVP and highlight the prevalence of this drug by recreational users.  Although the abuse of alpha PVP is not new, it is certainly a designer drug trend that deserves the attention of public health authorities, law enforcement, medical examiners, and toxicology laboratories. 

Register today and learn more about Flakka, Alpha PVP, and other novel psychoative substances as well as how they are effecting the world of toxicology.  The webinar will be held Monday, June 1st at 1pm and will last roughly a half hour.  You can register for the free webinar here